Functional TRPA1 Channels Regulate CD56^dimCD16⁺ NK Cell Cytotoxicity against Tumor Cells

Area of Science:

• Immunology
• Cell Biology
• Channelopathies

Background:

• Transient Receptor Potential Ankyrin 1 (TRPA1) channels are present on immune cells, but their specific function in innate and adaptive immunity, particularly in Natural Killer (NK) cells, remains unclear.
• Understanding TRPA1's role in NK cell subsets is crucial for exploring novel immunotherapeutic strategies.

Purpose of the Study:

• To investigate the expression and functional role of TRPA1 channels in human NK cells.
• To determine how TRPA1 activation influences NK cell activity, surface marker expression, and cytotoxicity against tumor cells.

Main Methods:

• Flow cytometry (FACS) was used to detect TRPA1 expression on different NK cell subpopulations (CD56dimCD16+ and CD56brightCD16-).
• TRPA1 was activated using allyl isothiocyanate (AITC) and its effects on intracellular calcium flux, surface marker expression (NKp44, CD16, CD8, CD158a, CD159a, NKG2d, NKp46), granzyme production, CD107 expression, and cytotoxicity against K562 and melanoma cell lines were assessed.
• TRPA1 antagonist HC-030031 was used to confirm TRPA1-specific effects.

Main Results:

• TRPA1 was highly expressed on CD56dimCD16+ NK cells but not on CD56brightCD16- cells.
• AITC-induced TRPA1 activation led to calcium influx, altered expression of NK cell markers, increased granzyme production and CD107 expression, and enhanced NK cell-mediated cytotoxicity against tumor cell lines.
• TRPA1 activation also modulated NK cell survival, suggesting a regulatory role in limiting excessive cytotoxicity.

Conclusions:

• TRPA1 channels are functionally expressed on cytotoxic CD56dimCD16+ NK cells and play a significant role in regulating their anti-tumor functions.
• TRPA1 agonists represent a potential therapeutic approach to enhance the immune system's anti-tumor response in cancer immunotherapy.